IonQ, Inc. filings document a public quantum technology company with common stock, warrants and recurring capital-structure disclosures. Its 8-K reports include operating and financial results, material-event updates, registration rights agreements, unregistered equity issuances, resale prospectus supplements and acquisition-related share issuances, including the completed Skyloom Global acquisition.
IonQ proxy materials cover shareholder voting matters, board governance, executive compensation and pay-versus-performance disclosures. The company’s filing record also reflects material agreements, warrant and common-stock terms, financial reporting furnished with earnings releases, and governance matters connected to its quantum computing, networking, sensing, security and space-based data businesses.
IonQ, Inc. completed an underwritten offering that included 20,500,000 shares of common stock, 29,500,000 pre-funded warrants to purchase 29,500,000 shares, and 100,000,000 Series C warrants to purchase 100,000,000 shares. The offering closed October 16, 2026. Each common share or pre-funded warrant was offered with two Series C warrants at a combined public price of $40.00; the securities were issued separately, not as a unit. J.P. Morgan Securities LLC was the sole underwriter under an agreement dated October 14, 2026.
The warrants are exercisable immediately upon issuance through and including the seven-year anniversary of their initial issuance. The exercise prices are $0.0001 per share for pre-funded warrants and $69.46 per share for Series C warrants. A holder and its Attribution Parties cannot exercise if doing so would result in beneficial ownership above 4.99%; the holder may increase that limit to no more than 9.99% or decrease it under the warrant agreements.
IonQ, Inc. is offering 20,500,000 common shares, 100,000,000 Series C Warrants and 29,500,000 Pre-funded Warrants, plus 129,500,000 common shares issuable upon exercise. The aggregate public offering price is $1,999,997,050.00; estimated net proceeds are approximately $1,988.5 million after underwriting discounts and estimated expenses. Proceeds are intended for working capital and general corporate purposes, including possible strategic acquisitions and partnerships.
Each common share is offered with two Series C Warrants for $40.00 combined; each Pre-funded Warrant with two Series C Warrants is $39.9999 combined. Exercise prices are $69.46 per Series C Warrant share and $0.0001 per Pre-funded Warrant share. Purchasers of common stock face immediate dilution of $34.52 per share. For the six months ended June 30, 2026, operating losses were $608.8 million, versus $236.3 million for the six months ended June 30, 2025. IonQ has not concluded that two material weaknesses in internal control over financial reporting assumed in the SkyWater acquisition are remediated. IonQ does not plan to list the Warrants on an exchange.
IonQ, Inc. is offering 20,500,000 common shares, 100,000,000 Series C Warrants, 29,500,000 Pre-funded Warrants and 129,500,000 common shares issuable upon exercise. Each common share or Pre-funded Warrant is paired with two Series C Warrants for a combined $40.00; each Pre-funded Warrant also has a $0.0001 exercise price remaining unpaid at issuance.
Estimated net proceeds are $1,988.5 million after underwriting discounts and estimated expenses, excluding warrant-exercise proceeds. IonQ intends to use the proceeds for working capital and general corporate purposes, including possible acquisitions and partnerships. Series C Warrants carry a $69.46 exercise price and expire October 16, 2033; purchasers face stated immediate dilution of $34.52 per share. IonQ reported operating losses of $608.8 million for the six months ended June 30, 2026, versus $236.3 million in 2025, and is remediating two material weaknesses assumed with its completed SkyWater acquisition. IonQ also entered into an agreement to acquire Elisity, subject to customary closing conditions including regulatory approvals, for $1.15 billion in stock subject to adjustments, with up to $150 million additional stock consideration if certain revenue milestones are achieved through January 31, 2028. IonQ does not intend to list the Warrants on an exchange.
IonQ, Inc. agreed to acquire all issued and outstanding shares of Elisity in an all-stock transaction valued at up to $1.3 billion. The agreement sets closing consideration at $1.15 billion in IonQ shares, reduced by leakage incurred since July 31, 2026, subject to customary permitted-leakage exceptions. Elisity’s securityholders may also receive up to $150 million in additional shares tied to revenue milestones.
The share count will use IonQ’s volume-weighted average price for the 20 trading days immediately preceding, but not including, the third business day before closing, with a price floor of $33.07 and a cap of $49.61 per share. IonQ also agreed to establish a $100 million restricted-stock-unit pool for continuing Elisity employees; grants are to follow closing and vest over four years, in addition to the merger consideration. Closing is expected in the fourth quarter of 2026, subject to customary conditions including regulatory approvals. The agreement may be terminated in certain circumstances if closing has not occurred by January 7, 2027. Consideration shares are to be issued under exemptions from Securities Act registration, including Section 4(a)(2), Regulation D and Regulation S.
The New York Stock Exchange filed a Form 25 notification for removal from listing and registration of IonQ, Inc.'s redeemable warrants. Each whole warrant is exercisable for one share of common stock at an exercise price of $11.50 per share.
IonQ, Inc. (IONQ) reported that officer Paul T. Dacier, CAO, CLO and Secretary, had 4,457 shares of Common Stock disposed of on September 11, 2026 to satisfy his tax liability in connection with the vesting of restricted stock units. The shares were sold at a weighted average price of $37.09 per share, with individual sale prices ranging from $36.35 to $37.62. After this tax-withholding disposition, he directly owns 100,001 shares of IonQ common stock. No Rule 10b5-1 trading plan is reported for this transaction.
IonQ, Inc. (IONQ) reported that its CFO & COO, Inder M Singh, had 6,272 shares of common stock disposed of on September 11, 2026, to pay tax liability arising from vesting of restricted stock units. The shares were withheld at a weighted average price of $37.0932 per share, leaving him with 408,614 directly held shares.
IonQ, Inc. (IONQ) reports that President and CEO Niccolo de Masi disposed of 16,121 shares of common stock on September 11, 2026, through a tax-withholding disposition tied to the vesting of restricted stock units. The weighted average sale price was $37.0932 per share, with sales executed between $36.35 and $37.62. Following this transaction, de Masi directly holds 1,123,426 shares of IonQ common stock.
IonQ, Inc. (IONQ) reported that director and special advisor Raymond John W sold common stock in an open-market or private transaction on September 10, 2026. He sold 2,407 shares at a price of $37.21 per share, leaving him with 77,741 shares held directly after the sale.
The filing states that this transaction was carried out under a Rule 10b5-1 trading plan that he adopted on March 19, 2026.
IonQ, Inc. (IONQ) received a notice that officer Paul T. Dacier intends to sell shares of common stock under Rule 144. The planned sale relates to 4,890 shares associated with the vesting of restricted stock units, with shares sold to cover tax withholding obligations.